Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance

ACADIA Pharmaceuticals Inc.Trade
Consumer Staples Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

ACADIA Pharmaceuticals Inc. vs Consumer Staples Select Sector SPDR Fund — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.84 (market cap $5.07B), while Consumer Staples Select Sector SPDR Fund trades at $84.49. The key difference: ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.

ACADXLP
Market Cap
$5.07B
Sector
Health
52-Week High
$29.41$90.00
52-Week Low
$20.06$75.61
Enterprise Value
$4.19B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Read more on ACAD

About Consumer Staples Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.

Read more on XLP